Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs

AIMS: The advent of direct-acting antivirals for hepatitis C virus (HCV) and limited effectiveness of prevention have generated interest in “Treatment as Prevention” (TasP), in which those most likely to transmit HCV (i.e. people who inject drugs [PWID]) are treated to reduced secondary transmission...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffin, Phillip O., Santos, Glenn-Milo, Behar, Emily, Hern, Jaclyn, Walker, John, Matheson, Tim, Kinnard, Elizabeth N., Silvis, Janelle, Vittinghoff, Eric, Fox, Rena, Page, Kimberley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546233/
https://www.ncbi.nlm.nih.gov/pubmed/31158245
http://dx.doi.org/10.1371/journal.pone.0217471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546233/
https://www.ncbi.nlm.nih.gov/pubmed/31158245
http://dx.doi.org/10.1371/journal.pone.0217471

Ejemplares similares